Conference Scene: Recent advancements in immunopotentiators for modern vaccines

A.M. Harandi, V.E.J.C. Schijns

Research output: Contribution to journalComment/Letter to the editorAcademic

4 Citations (Scopus)

Abstract

Vaccines have proved to be the most successful preventive measure against a variety of infectious diseases. Owing to the potential safety concerns associated with the use of live-attenuated or killed pathogens, there is currently a drive to discover defined subunits of pathogens or recombinant molecules for new vaccines. The development of safe and potent vaccine adjuvants with the ability to enhance and direct broad and durable immune responses to these otherwise poorly immunogenic antigens is hence a top priority. The 4th International Conference on Immunopotentiators in Modern Vaccines, held in Porto, Portugal, 6–8 April 2011, offered an international forum for reviewing the current status of research and development, as well as application of novel immunopotentiators and vaccine adjuvants to vaccines. During the 3-day meeting, a stimulating and diverse mixture of presentations were presented. This report attempts to highlight a selected number of presentations of this meeting
Original languageEnglish
Pages (from-to)1297-1301
JournalImmunotherapy
Volume3
Issue number11
DOIs
Publication statusPublished - 2011

Fingerprint Dive into the research topics of 'Conference Scene: Recent advancements in immunopotentiators for modern vaccines'. Together they form a unique fingerprint.

Cite this